UX007
UX007G-CL202
Phase 2 small_molecule terminated
Quick answer
UX007 for Glucose Transporter Type 1 Deficiency Syndrome is a Phase 2 program (small_molecule) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ultragenyx Pharmaceutical
- Indication
- Glucose Transporter Type 1 Deficiency Syndrome
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated